HCA Healthcare, Inc. $HCA Shares Purchased by Los Angeles Capital Management LLC

Key Points

• Los Angeles Capital Management sharply increased its HCA Healthcare stake by 1,097.4% in the fourth quarter, ending with 288,017 shares valued at about $134.4 million.
• HCA reported Q1 2026 revenue of $19.1 billion, topping expectations slightly and marking 4.3% year-over-year growth, even though earnings per share came in a bit below estimates.
• The company is expanding through both acquisitions and operations, including buying 17 urgent care clinics in the Carolinas and opening a new Galen College of Nursing campus to support its workforce pipeline.

Los Angeles Capital Management LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1,097.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 288,017 shares of the company's stock after buying an additional 263,963 shares during the quarter. Los Angeles Capital Management LLC owned 0.13% of HCA Healthcare worth $134,446,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Cookson Peirce & Co. Inc. increased its position in shares of HCA Healthcare by 20.0% in the 4th quarter. Cookson Peirce & Co. Inc. now owns 1,268 shares of the company's stock worth $592,000 after purchasing an additional 211 shares during the last quarter. Havemeyer Place LP bought a new stake in shares of HCA Healthcare in the 4th quarter worth about $878,000. 111 Capital increased its position in shares of HCA Healthcare by 67.0% in the 4th quarter. 111 Capital now owns 1,468 shares of the company's stock worth $685,000 after purchasing an additional 589 shares during the last quarter. Vestcor Inc increased its position in shares of HCA Healthcare by 15.2% in the 4th quarter. Vestcor Inc now owns 26,268 shares of the company's stock worth $12,263,000 after purchasing an additional 3,473 shares during the last quarter. Finally, MCF Advisors LLC increased its position in shares of HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company's stock worth $34,000 after purchasing an additional 49 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA reported first-quarter 2026 revenue of $19.1 billion, highlighting continued top-line growth and reinforcing the company’s scale and demand trends. HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
• Positive Sentiment: HCA acquired 17 urgent care clinics in the Carolinas, a move that expands its outpatient network and could support future patient volume and revenue growth. HCA acquires 17 urgent care clinics in the Carolinas
• Positive Sentiment: HCA Healthcare-owned Galen College of Nursing opened a new campus near Space Center Houston, which may help strengthen the company’s nursing pipeline and ease labor constraints over time. HCA Healthcare-owned nursing college opens new campus near Space Center Houston
• Neutral Sentiment: HCA Houston Healthcare Clear Lake is hosting a ribbon cutting for a blood cancer unit, a local service expansion that is positive operationally but likely limited in near-term stock impact. HCA Houston Healthcare Clear Lake to host ribbon cutting for blood cancer unit
• Neutral Sentiment: Additional community and employee-related announcements, including a butterfly release event and leadership updates, are supportive of HCA’s brand but are not likely to move the stock materially. HCA Florida Healthcare hosts a butterfly release to honor cancer patients and their loved ones
• Neutral Sentiment: HCA also hosted emergency response team training, which reflects ongoing operational readiness but is not a major financial catalyst. HCA Healthcare hosts emergency response team training at Tristar Skyline Medical Center

HCA Healthcare Trading Up 2.9%

Shares of NYSE:HCA opened at $372.29 on Friday. The firm's 50 day moving average is $439.51 and its two-hundred day moving average is $477.20. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The firm has a market capitalization of $82.59 billion, a P/E ratio of 12.80, a PEG ratio of 1.18 and a beta of 1.12.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the previous year, the business posted $6.45 EPS. HCA Healthcare's revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is 10.73%.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. Robert W. Baird cut their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating on the stock in a report on Wednesday, April 15th. Jefferies Financial Group restated a "buy" rating and issued a $525.00 target price on shares of HCA Healthcare in a research note on Friday, April 24th. Oppenheimer decreased their target price on HCA Healthcare from $540.00 to $520.00 and set an "outperform" rating for the company in a research note on Monday, April 27th. Cantor Fitzgerald restated an "overweight" rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Finally, Stephens decreased their target price on HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a research note on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $506.14.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.